News and Trends 27 Apr 2023
Biogen ALS drug gets FDA ok
The U.S. Food and Drug Administration (FDA) has approved Biogen’s QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic…
Neurodegenerative disease
- Latest Posts
In Depth 21 Apr 2023
Gut microbiome: a promising target for Parkinson’s
Home to around a thousand microbial species, the gut’s role in nutrient and drug metabolism is pivotal for immune function.…
News and Trends 31 Mar 2023
€260M fund addresses dementia investment shortfall
EQT Life Sciences has closed its inaugural LSP Dementia Fund, raising approximately €260 million ($283 million) in fee-generating assets under…
News and Trends 8 Mar 2023
The challenges of tackling dementia in women
Dr Andrea Pfeifer, chief executive officer of AC Immune SA, talks to Labiotech about dementia research, and how dementia affects…
ADVERTISEMENT
More News! 2 Mar 2023
Could new dementia treatment come from intestinal bacteria discovery?
Dementia with Lewy bodies (DLB), one of the most common forms of dementia, has no cure. Previous studies suggested that…
News and Trends 14 Feb 2023
Minoryx Therapeutics announces X-linked adrenoleukodystrophy data
Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead candidate, leriglitazone, has been published…
News and Trends 14 Feb 2023
Astex and Cardiff University Medicines Discovery Institute to collaborate on neurodegenerative diseases
Astex Pharmaceuticals (UK), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and…
News and Trends 24 Jan 2023
Ubiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high…
News and Trends 12 Jan 2023
JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for multinational research on large scale…
News and Trends 12 Dec 2022
Japanese research offers hope for Fukuyama muscular dystrophy patients
Fukuyama congenital muscular dystrophy (FCMD) is the second most common form of childhood muscular dystrophy in Japan. The disease manifests…
News and Trends 7 Dec 2022
Scientists identify genetic variant causing ALS in some patients
Researchers at Nagoya University in Japan have identified a novel genetic variant found in some patients with amyotrophic lateral sclerosis…
News and Trends 30 Nov 2022
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT N279K and ioGlutamatergic Neurons MAPT…
News and Trends 23 Nov 2022
Immune cells in ALS patients can predict the course of the disease
By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease…
News and Trends 17 Nov 2022
FundaMental Pharma launches with €10M to advance first-in-class neuroprotectant
FundaMental Pharma GmbH, a preclinical neuroscience company spun out of Heidelberg University in Germany, has launched with €10 million ($10.4…
News and Trends 15 Nov 2022
BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat pathologies such as amyotrophic lateral…
Startup Scout 10 Nov 2022
ResQ Biotech is using bacteria to discover Alzheimer’s treatments
Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech…
ADVERTISEMENT
News and Trends 10 Nov 2022
Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS
NRG Therapeutics, Ltd. has closed a £16 million ($18.2 million) series A financing. The funding was led by Omega Funds…
News and Trends 4 Nov 2022
Centogene launches rare and neurodegenerative disease Biodata Network
German company, Centogene N.V., today (November 4) announced its launch of Biodata Network, a portfolio of data-driven partnering solutions including…
News and Trends 29 Sep 2022
Human cells can now help scientists accelerate cure for neurodegenerative diseases
Cell products providing a scalable source of human cells can now help scientists study neurogenerative diseases in human context. UK-based,…
News and Trends 22 Sep 2022
Promising MND drug slows disease progression
Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point…
